Related Experiment Video
Updated: May 12, 2026

09:13
Optimized Protocol for the Extraction of Proteins from the Human Mitral Valve
Published on: June 14, 2017
Protein S.
Mirta Hepner1, Vasiliki Karlaftis
1Laboratorio de Hemostasia y Trombosis, Hospital de Pediatría Prof. Dr. Juan P. Garrahan, Buenos Aires, Argentina.
Methods in Molecular Biology (Clifton, N.J.)
|April 3, 2013
Summary
Protein S (PS) deficiency can cause excessive blood clotting. Functional assays are recommended for initial testing alongside free PS immunoassays, but require caution due to potential interferences.
Area of Science:
- Biochemistry
- Hematology
- Molecular Biology
Background:
- Protein S (PS) is a vitamin K-dependent glycoprotein crucial for regulating blood coagulation.
- Free PS acts as a cofactor for activated protein C (APC) and also possesses APC-independent inhibitory functions.
- Deficiencies in PS, either acquired or hereditary, lead to uncontrolled thrombin generation and thrombophilia.
Purpose of the Study:
- To evaluate the diagnostic utility of various assays for Protein S deficiency.
- To compare the effectiveness of functional and immunological assays in detecting PS defects.
- To provide guidance on appropriate testing strategies for PS deficiency, considering potential interferences.
Main Methods:
- Review of existing literature on Protein S function and deficiency testing.
- Analysis of the advantages and limitations of functional PS assays versus immunological assays (free and total PS).
- Consideration of interference factors, such as lupus anticoagulant (LA), in assay selection.
Main Results:
- Hereditary PS deficiencies are caused by numerous mutations, making DNA sequencing impractical for routine diagnosis.
- Functional PS assays can detect deficiencies missed by free PS immunoassays.
- PS antigen assays are widely adopted in laboratories, but functional assays offer complementary diagnostic information.
- Functional assays are susceptible to interference, necessitating careful interpretation and specific recommendations in cases like LA presence.
Conclusions:
- Functional PS assays, alongside free PS immunoassays, are recommended for initial testing of PS deficiency, despite potential interferences.
- The choice of assay may depend on specific clinical contexts, such as the presence of lupus anticoagulant.
- Routine molecular characterization of PS mutations is not currently indicated for clinical management of thrombophilia.
More Related Videos
Related Concept Videos
The Proteasome
Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
The Proteasome
Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3 (ubiquitin...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3 (ubiquitin...
The Proteasome Structure
The ubiquitin-proteasome pathway is a well-known mechanism utilized by eukaryotic cells to remove cytoplasmic proteins that are misfolded, damaged, or no longer needed. In this pathway, the protein that needs to be eliminated undergoes a process called ubiquitination, where a chain of ubiquitin molecules is attached to the 48th lysine residue of the target protein. This ubiquitin modification helps the proteasome distinguish between a target protein and a healthy protein.
The proteasome is an...
The proteasome is an...
Protein Modifications in the RER
Modification of secretory and transmembrane proteins entering the rough ER begins in the ER lumen. These modifications aid in protein folding and stabilize the acquired tertiary structure. Protein modifications in the rough ER co-occur at different stages of protein folding.
Broadly, these modifications can be categorized into four main categories — glycosylation, formation of disulfide bonds, assembly of protein subunits, and specific proteolytic cleavages like removal of signal sequences.
Broadly, these modifications can be categorized into four main categories — glycosylation, formation of disulfide bonds, assembly of protein subunits, and specific proteolytic cleavages like removal of signal sequences.
Single-Strand DNA Binding Proteins
For successful DNA replication, the unwinding of double-stranded DNA must be accompanied by stabilization and protection of the separated single strands of the DNA. This crucial task is performed by single-strand DNA-binding (SSB) proteins. They bind to the DNA in a sequence-independent manner, which means that the nitrogenous bases of the DNA need not be present in a specific order for binding of SSB proteins to it. The binding of SSB proteins straightens single-stranded DNA (ssDNA) and makes...
Protein-protein Interfaces
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a polypeptide...

